<--- Back to Details
First PageDocument Content
Env / DNA vaccination / HLA-B / HIV / HLA-A / Antigen / CD4 / Immunogenicity / Long-term nonprogressor / HIV/AIDS / Biology / Genetics
Date: 2007-02-19 14:47:54
Env
DNA vaccination
HLA-B
HIV
HLA-A
Antigen
CD4
Immunogenicity
Long-term nonprogressor
HIV/AIDS
Biology
Genetics

HIV CTL Epitopes CTL Table 15: HXB2 Location

Add to Reading List

Source URL: www.hiv.lanl.gov

Download Document from Source Website

File Size: 110,91 KB

Share Document on Facebook

Similar Documents

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200

DocID: 1uuzW - View Document

Biology / Molecular biology / Biochemistry / Chemistry / Gene delivery / DNA / Boehringer Ingelheim / DNA vaccination / Plasmid / Boehringer / Agarose gel electrophoresis / Alkaline lysis

Microsoft PowerPoint - Flyer pDNA

DocID: 1qqYL - View Document

Medicine / Microbiology / Clinical medicine / Ebola / Vaccines / Vaccination / Animal virology / Biological weapons / Ebola virus / DNA vaccination / Immunogenicity / Virus

Microsoft Word - jiu511.doc

DocID: 1qpVj - View Document

Zoonoses / Biological weapons / Tropical diseases / Animal virology / Ebola / Ebola virus / Marburg virus disease / Vaccine / DNA vaccination / Virus / Marburg virus / Vaccinia

SUPPLEMENT ARTICLE Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection

DocID: 1pCnO - View Document

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. • Founded 1999, Clague Hodgson, Ph.D. • Chief Scientific Officer, VP, R&D, Jim Williams, Ph

DocID: 1jJjX - View Document